GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of IKNA
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Ikena Oncology, Inc. stock price down 2.26% on Monday
(Updated on Apr 22, 2024)

Sell candidate since Apr 02, 2024 Loss -2.62% PDF

The Ikena Oncology, Inc. stock price fell by -2.26% on the last day (Monday, 22nd Apr 2024) from $1.33 to $1.30. During the last trading day the stock fluctuated 8.66% from a day low at $1.27 to a day high of $1.38. The price has fallen in 6 of the last 10 days and is down by -1.52% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -98 thousand shares and in total, 234 thousand shares were bought and sold for approximately $304.31 thousand.

The stock lies in the lower of a very wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $1.24 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -2.24% during the next 3 months and, with a 90% probability hold a price between $1.21 and $1.55 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

IKNA Signals & Forecast

Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Ikena Oncology, Inc. stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $1.41. On a fall, the stock will find some support from the short-term average at $1.29. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. A sell signal was issued from a pivot top point on Friday, April 19, 2024, and so far it has fallen -2.26%. Further fall is indicated until a new bottom pivot has been found. Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk.

Support, Risk & Stop-loss for Ikena Oncology, Inc. stock

Ikena Oncology, Inc. finds support from accumulated volume at $1.29 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day, but be aware of low or falling volume as this increases the risk. During the last day, the stock moved $0.110 between high and low, or 8.66%. For the last week the stock has had daily average volatility of 7.70%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (IKNA) For The Upcoming Trading Day Of Tuesday 23rd

For the upcoming trading day on Tuesday, 23rd we expect Ikena Oncology, Inc. to open at $1.32, and during the day (based on 14 day Average True Range), to move between $1.20 and $1.40, which gives a possible trading interval of +/-$0.105 (+/-8.04%) up or down from last closing price. If Ikena Oncology, Inc. takes out the full calculated possible swing range there will be an estimated 16.08% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $1.29 (0.77%) than the resistance at $1.39 (6.92%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Ikena Oncology, Inc. stock A Buy?

Ikena Oncology, Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

Current score: -4.030 Sell Candidate Unchanged

Predicted Opening Price for Ikena Oncology, Inc. of Tuesday, April 23, 2024

Fair opening price April 23, 2024 Current price
$1.32 ( 1.28%) $1.30

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for IKNA

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 1.43 9.74 %
R2 1.38 6.51 %
R1 1.36 4.51 %
Current price: 1.30
Support S1 1.27 -1.95 %
S2 1.25 -3.95 %
S3 1.21 -7.18 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 1.52 16.92 %
R2 1.46 12.31 %
R1 1.39 6.92 %
Current price 1.30
Support S1 1.29 -0.769%
S2 1.28 -1.54%
S3 1.27 -2.31%

FAQ

What is the symbol for Ikena Oncology, Inc. Stock and on which exchange is it traded?
The symbol for Ikena Oncology, Inc. is IKNA and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Ikena Oncology, Inc. Stock?
Ikena Oncology, Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

How to buy Ikena Oncology, Inc. Stock?
Ikena Oncology, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Ikena Oncology, Inc. Stock.

What's the current price of Ikena Oncology, Inc. Stock?
As of the end of day on the Apr 22, 2024, the price of an Ikena Oncology, Inc. (IKNA) share was $1.30.

What is the 52-week high and low for Ikena Oncology, Inc. Stock?
The 52-week high for Ikena Oncology, Inc. Stock is $7.64 and the 52-week low is $1.02.

What is the market capitalization of Ikena Oncology, Inc. Stock?
As of the Apr 22, 2024, the market capitalization of Ikena Oncology, Inc. is 62.736M.

When is the next earnings date for Ikena Oncology, Inc.?
The upcoming earnings date for Ikena Oncology, Inc. is May 20, 2024.
Click to get the best stock tips daily for free!

About Ikena Oncology, Inc.

Ikena Oncology. Ikena Oncology, Inc., a targeted oncology company, focuses on developing medicines tailored to biomarker-defined patient groups for specific unmet needs. Its lead targeted oncology product candidate is IK-930, an oral small molecule inhibitor of the transcriptional enhanced associate domain, transcription factor in the Hippo signaling pathway. It is also developing a small molecule inhibitor program against ERK5 in the RAS signaling pathway; IK-1... IKNA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT